News

Radiation From Backscatter X-Ray Scans Poses Little Cancer Risk

Publish date: March 28, 2011

 

FROM ARCHIVES OF INTERNAL MEDICINE

Mr. Mehta and Dr. Smith-Bindman reported that they have no financial disclosures. Dr. Morin reported that he has no relevant financial disclosures.

The NRCP had a grant from the Food and Drug Administration for this commentary by Dr. Schauer. Dr. Schauer had no other relevant financial disclosures. Dr. Brenner had no relevant financial disclosures.

Pages

Recommended Reading

FDA Okay Expected Soon for Melanoma Drug Ipilimumab
MDedge Internal Medicine
Bone Micrometastases Show No Survival Impact in Early Breast Cancer
MDedge Internal Medicine
NCCN Breast Guidelines Stand by Bevacizumab
MDedge Internal Medicine
FDA Panel Supports Device That Targets Brain Tumors
MDedge Internal Medicine
More NCI Cooperative Groups Forming Alliances
MDedge Internal Medicine
Thin Endometrial Echo Complex Does Not Rule Out Cancer
MDedge Internal Medicine
NCCN Upgrades Rituximab Regimens for Follicular Lymphoma
MDedge Internal Medicine
Ipilimumab Approval Was Desperately Needed
MDedge Internal Medicine
FDA: Ipilimumab Approved for Metastatic Melanoma
MDedge Internal Medicine
NCI’s Cancer Research Gambit
MDedge Internal Medicine